Skip to main content
Top
Published in: Inflammation 2/2017

01-04-2017 | ORIGINAL ARTICLE

CDK11p58 Promotes Microglia Activation via Inducing Cyclin D3 Nuclear Localization

Authors: Biyu Shen, Tianyu Gu, Haoyang Chen, Qian Zhao, Yan He, Li Zhu, Wengting Fu, Zhiming Cui

Published in: Inflammation | Issue 2/2017

Login to get access

Abstract

Microglia activation has been implicated in the pathogenesis of many neurological diseases. These reactive microglia are capable of producing a variety of proinflammatory mediators and potentially neurotoxic compounds. The increase of cell number and expression of CD11b are the main features of activated microglia. In this study, we examined the suppressive effects of CDK11p58 on microglia activation induced by lipopolysaccharide (LPS) in vitro. We found that in the activated microglia, the expression of CDK11p58 increased and the overexpression of CDK11p58 could reduce the increased proliferation and CD11b expression in LPS-activated microglia. Such suppressive effects might be resulted from the interaction with cyclin D3 which promoted CDK11p58 nuclear localization. Our results suggested that CDK11p58 acted to regulate microglia activation through CDK11p58 and cyclin D3 interaction.
Literature
1.
go back to reference Bajić, V.P., B. Su, H.G. Lee, W. Kudo, S.L. Siedlak, L. Zivković, B. Spremo-Potparević, N. Djelic, Z. Milicevic, A.K. Singh, L.M. Fahmy, X. Wang, M.A. Smith, and X. Zhu. 2011. Mislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer disease. Cell Mol Biol Lett 16(3): 359–372. doi:10.2478/s11658-011-0011-2. Bajić, V.P., B. Su, H.G. Lee, W. Kudo, S.L. Siedlak, L. Zivković, B. Spremo-Potparević, N. Djelic, Z. Milicevic, A.K. Singh, L.M. Fahmy, X. Wang, M.A. Smith, and X. Zhu. 2011. Mislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer disease. Cell Mol Biol Lett 16(3): 359–372. doi:10.​2478/​s11658-011-0011-2.
1.
go back to reference Behrendt, P., P. Arnold, M. Brueck, U. Rickert, R. Lucius, S. Hartmann, C. Klotz, and R. Lucius. 2016. A Helminth Protease Inhibitor Modulates the Lipopolysaccharide-Induced Proinflammatory Phenotype of Microglia in vitro. Neuroimmunomodulation 23(2): 109–121. doi:10.1159/000444756.CrossRefPubMed Behrendt, P., P. Arnold, M. Brueck, U. Rickert, R. Lucius, S. Hartmann, C. Klotz, and R. Lucius. 2016. A Helminth Protease Inhibitor Modulates the Lipopolysaccharide-Induced Proinflammatory Phenotype of Microglia in vitro. Neuroimmunomodulation 23(2): 109–121. doi:10.​1159/​000444756.CrossRefPubMed
7.
go back to reference Goldmann, T., P. Wieghofer, P.F. Muller, Y. Wolf, D. Varol, S. Yona, S.M. Brendecke, K. Kierdorf, O. Staszewski, M. Datta, T. Luedde, M. Heikenwalder, S. Jung, and M. Prinz. 2013. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nature Neuroscience 16(11): 1618–1626. doi:10.1038/nn.3531.CrossRefPubMed Goldmann, T., P. Wieghofer, P.F. Muller, Y. Wolf, D. Varol, S. Yona, S.M. Brendecke, K. Kierdorf, O. Staszewski, M. Datta, T. Luedde, M. Heikenwalder, S. Jung, and M. Prinz. 2013. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nature Neuroscience 16(11): 1618–1626. doi:10.​1038/​nn.​3531.CrossRefPubMed
8.
go back to reference Guo, S., Y. Liu, R. Ma, J. Li, and B. Su. 2016. Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by the excess microglia-mediated inflammation. American Journal of Translational Research 8(6): 2631–2640.PubMedPubMedCentral Guo, S., Y. Liu, R. Ma, J. Li, and B. Su. 2016. Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by the excess microglia-mediated inflammation. American Journal of Translational Research 8(6): 2631–2640.PubMedPubMedCentral
9.
go back to reference Hilton, G.D., B.A. Stoica, K.R. Byrnes, and A.I. Faden. 2008. Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma. Journal of Cerebral Blood flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism 28(11): 1845–1859. doi:10.1038/jcbfm.2008.75.CrossRef Hilton, G.D., B.A. Stoica, K.R. Byrnes, and A.I. Faden. 2008. Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma. Journal of Cerebral Blood flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism 28(11): 1845–1859. doi:10.​1038/​jcbfm.​2008.​75.CrossRef
11.
go back to reference Lee, Y.Y., E.J. Lee, J.S. Park, S.E. Jang, D.H. Kim, and H.S. Kim. 2016. Anti-Inflammatory and Antioxidant Mechanism of Tangeretin in Activated Microglia. Journal of Neuroimmune Pharmacology : The Official Journal of the Society on NeuroImmune Pharmacology 11(2): 294–305. doi:10.1007/s11481-016-9657-x.CrossRef Lee, Y.Y., E.J. Lee, J.S. Park, S.E. Jang, D.H. Kim, and H.S. Kim. 2016. Anti-Inflammatory and Antioxidant Mechanism of Tangeretin in Activated Microglia. Journal of Neuroimmune Pharmacology : The Official Journal of the Society on NeuroImmune Pharmacology 11(2): 294–305. doi:10.​1007/​s11481-016-9657-x.CrossRef
12.
go back to reference Lewis, D.K., A.B. Johnson, S. Stohlgren, A. Harms, and F. Sohrabji. 2008. Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats. Journal of Neuroimmunology 195(1–2): 47–59.CrossRefPubMedPubMedCentral Lewis, D.K., A.B. Johnson, S. Stohlgren, A. Harms, and F. Sohrabji. 2008. Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats. Journal of Neuroimmunology 195(1–2): 47–59.CrossRefPubMedPubMedCentral
13.
14.
go back to reference Menet, V., M. Gimenez y Ribotta, N. Chauvet, M.J. Drian, J. Lannoy, E. Colucci-Guyon, and A. Privat. 2001. Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. The Journal of Neuroscience 21(16): 6147–6158.PubMed Menet, V., M. Gimenez y Ribotta, N. Chauvet, M.J. Drian, J. Lannoy, E. Colucci-Guyon, and A. Privat. 2001. Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. The Journal of Neuroscience 21(16): 6147–6158.PubMed
15.
go back to reference Pastore N, Brady OA, Diab HI, Martina JA, Sun L, Huynh T, Lim JA, Zare H, Raben N, Ballabio A, Puertollano R. 2016. TFEB and TFE3 cooperate in the regulation of the innate immune response in activated macrophages. Autophagy 1–19. doi:10.1080/15548627.2016.1179405 Pastore N, Brady OA, Diab HI, Martina JA, Sun L, Huynh T, Lim JA, Zare H, Raben N, Ballabio A, Puertollano R. 2016. TFEB and TFE3 cooperate in the regulation of the innate immune response in activated macrophages. Autophagy 1–19. doi:10.​1080/​15548627.​2016.​1179405
17.
go back to reference Tateda, S., H. Kanno, H. Ozawa, A. Sekiguchi, K. Yahata, S. Yamaya, and E. Itoi. 2016. Rapamycin suppresses microglial activation and reduces the development of neuropathic pain after spinal cord injury. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. doi:10.1002/jor.23328. Tateda, S., H. Kanno, H. Ozawa, A. Sekiguchi, K. Yahata, S. Yamaya, and E. Itoi. 2016. Rapamycin suppresses microglial activation and reduces the development of neuropathic pain after spinal cord injury. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. doi:10.​1002/​jor.​23328.
18.
go back to reference Tsou, Y.C., H.H. Wang, C.C. Hsieh, K.H. Sun, G.H. Sun, R.S. Jhou, T.I. Lin, S.Y. Lu, H.Y. Liu, and S.J. Tang. 2016. Down-regulation of BNIP3 by olomoucine, a CDK inhibitor, reduces LPS- and NO-induced cell death in BV2 microglial cells. Neuroscience Letters 628: 186–193. doi:10.1016/j.neulet.2016.06.040.CrossRefPubMed Tsou, Y.C., H.H. Wang, C.C. Hsieh, K.H. Sun, G.H. Sun, R.S. Jhou, T.I. Lin, S.Y. Lu, H.Y. Liu, and S.J. Tang. 2016. Down-regulation of BNIP3 by olomoucine, a CDK inhibitor, reduces LPS- and NO-induced cell death in BV2 microglial cells. Neuroscience Letters 628: 186–193. doi:10.​1016/​j.​neulet.​2016.​06.​040.CrossRefPubMed
19.
go back to reference Yuan, Y., M. Fang, C.Y. Wu, and E.A. Ling. 2016. Scutellarin as a Potential Therapeutic Agent for Microglia-Mediated Neuroinflammation in Cerebral Ischemia. Neuromolecular Medicine. doi:10.1007/s12017-016-8394-x. Yuan, Y., M. Fang, C.Y. Wu, and E.A. Ling. 2016. Scutellarin as a Potential Therapeutic Agent for Microglia-Mediated Neuroinflammation in Cerebral Ischemia. Neuromolecular Medicine. doi:10.​1007/​s12017-016-8394-x.
21.
go back to reference Zhang, S., M. Cai, S. Zhang, S. Xu, S. Chen, X. Chen, C. Chen, and J. Gu. 2002. Interaction of p58(PITSLRE), a G2/M-specific protein kinase, with cyclin D3. The Journal of Biological Chemistry 277(38): 35314–35322.CrossRefPubMed Zhang, S., M. Cai, S. Zhang, S. Xu, S. Chen, X. Chen, C. Chen, and J. Gu. 2002. Interaction of p58(PITSLRE), a G2/M-specific protein kinase, with cyclin D3. The Journal of Biological Chemistry 277(38): 35314–35322.CrossRefPubMed
22.
23.
go back to reference Zhou, Y., J.K. Shen, F.J. Hornicek, Q. Kan, and Z. Duan. 2016. The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer. Oncotarget. doi:10.18632/oncotarget.8519. Zhou, Y., J.K. Shen, F.J. Hornicek, Q. Kan, and Z. Duan. 2016. The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer. Oncotarget. doi:10.​18632/​oncotarget.​8519.
24.
go back to reference Zong, H., Y. Chi, Y. Wang, Y. Yang, L. Zhang, H. Chen, J. Jiang, Z. Li, Y. Hong, H. Wang, X. Yun, and J. Gu. 2007. Cyclin D3/CDK11p58 complex is involved in the repression of androgen receptor. Molecular and Cellular Biology 27(20): 7125–7142. doi:10.1128/MCB.01753-06.CrossRefPubMedPubMedCentral Zong, H., Y. Chi, Y. Wang, Y. Yang, L. Zhang, H. Chen, J. Jiang, Z. Li, Y. Hong, H. Wang, X. Yun, and J. Gu. 2007. Cyclin D3/CDK11p58 complex is involved in the repression of androgen receptor. Molecular and Cellular Biology 27(20): 7125–7142. doi:10.​1128/​MCB.​01753-06.CrossRefPubMedPubMedCentral
Metadata
Title
CDK11p58 Promotes Microglia Activation via Inducing Cyclin D3 Nuclear Localization
Authors
Biyu Shen
Tianyu Gu
Haoyang Chen
Qian Zhao
Yan He
Li Zhu
Wengting Fu
Zhiming Cui
Publication date
01-04-2017
Publisher
Springer US
Published in
Inflammation / Issue 2/2017
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0510-z

Other articles of this Issue 2/2017

Inflammation 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.